Related Experiment Videos
Lipoprotein (a) and coronary heart disease
1Department of Medicine, University of Washington Medical Center, Seattle, USA.
Insights
Lipoprotein (a) may promote atherosclerosis, but its impact on coronary heart disease is influenced by LDL-cholesterol levels. This interaction might explain conflicting study results and suggests new treatment strategies.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Atherosclerosis Research
Background:
- Lipoprotein (a) [Lp(a)] has known proatherogenic and prothrombotic properties.
- Existing research shows a strong association between Lp(a) and coronary heart disease (CHD) severity.
- Conflicting findings question the significance of Lp(a) in atherosclerosis development.
Purpose of the Study:
- To investigate the potential modulation of Lp(a) pathogenicity by concurrent low-density lipoprotein cholesterol (LDL-C) levels.
- To explore the mechanisms underlying Lp(a) and LDL interaction in atherosclerosis.
- To discuss novel therapeutic strategies for managing elevated Lp(a) levels.
Main Methods:
- Review of existing human coronary atherosclerosis studies.
- Analysis of evidence suggesting modulation of Lp(a) effects by LDL-C.
- Examination of proposed molecular mechanisms for Lp(a)-LDL interaction.
Main Results:
- Evidence suggests that the pathogenicity of Lp(a) is significantly influenced by co-existing LDL-C levels.
- This modulation by LDL-C may reconcile discrepant findings on Lp(a)'s association with CHD.
- Potential mechanisms of Lp(a) and LDL interaction in promoting adverse cardiovascular effects are outlined.
Conclusions:
- The atherogenic role of Lp(a) is not absolute but is context-dependent, particularly influenced by LDL-C.
- Understanding the interplay between Lp(a) and LDL-C is crucial for accurate risk assessment in coronary heart disease.
- Targeting Lp(a) in conjunction with LDL-C management may offer improved therapeutic outcomes.
Abstract:
The role of lipoprotein (a) in the atherosclerotic process is continually being unraveled, and many of its potential proatherogenic and prothrombotic features have already been elucidated. Whereas most studies have demonstrated a strong association between lipoprotein (a) and the presence and severity of coronary heart disease, other groups have failed to observe such a relationship, which does question the importance of this particle in promoting atherosclerosis. Evidence from a study of human coronary atherosclerosis appears to demonstrate that the pathogenicity of lipoprotein (a) is modulated by concomitant LDL-cholesterol levels. Such a modulation of the pathogenicity of lipoprotein (a) may underlie the conflicting results regarding its association with coronary heart disease. This article will examine this possibility, and will also outline the potential mechanisms through which lipoprotein (a) may interact with LDL to exert its adverse effects. As a consequence of its interaction with LDL, alternative strategies for treating high levels of lipoprotein (a) will be discussed.